Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Droia parlays cancer fund success into genetic disease-themed vehicle as Golumbeski joins as partner

Firm expands into genetic diseases with €220M fund 

By stephen hansen, associate editor
May 11, 2021 7:50 PM UTC

Building on a portfolio of cancer-focused companies, Droia Ventures is now expanding its thematic fund model into genetic diseases with its largest vehicle yet, the €220 million fund Droia Genetic Disease.

The firm’s expansion also comes with a new partner. George Golumbeski has joined Droia after having spent nearly a decade as EVP of business development at Celgene Corp...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

DROIA

Droia Oncology Ventures